Home > Boards > US Listed > Medical - Drugs >

Abbvie Inc (ABBV)

ABBV RSS Feed
Add ABBV Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/1/2022 1:58:44 PM - Followers: 69 - Board type: Free - Posts Today: 0
ABBV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ABBV News: Amended Statement of Changes in Beneficial Ownership (4/a) 01:04 PM
ABBV News: AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson's Disease 04:15 AM
ABBV News: ABBV SHAREHOLDER ALERT: Jakubowitz Law Reminds AbbVie Shareholders of a Lead Plaintiff Deadline of June 6, 2022 01:45 AM
ABBV News: Statement of Changes in Beneficial Ownership (4) 05/18/2022 01:13:12 PM
ABBV News: Statement of Changes in Beneficial Ownership (4) 05/18/2022 01:13:02 PM
News News Alert: Amended Statement of Changes in Beneficial Ownership (4/a) 05/20/2022 01:04:45 PM
PostSubject
#707   ABBV 1Q22 CC transcript: DewDiligence 05/01/22 01:58:44 PM
#706   Didn't expect that. Bailed and wiped out most retired early 04/29/22 10:46:17 AM
#705   ABBV 1Q22 results: DewDiligence 04/29/22 08:29:28 AM
#704   Or perhaps we are done correcting? :) retired early 04/27/22 03:29:46 PM
#703   Thanks DewDilligence, you are most likely right about Just the facts maam 04/25/22 07:18:19 AM
#702   Androgel is now available as a generic, so DewDiligence 04/24/22 11:56:36 AM
#701   Question for the board, is AbbVie interested in Just the facts maam 04/24/22 07:05:00 AM
#700   Up too fast perhaps. Maybe a new 120 base? retired early 04/17/22 11:58:23 AM
#699   ABBV Chart conix 04/17/22 08:46:09 AM
#698   ABBV’s #2 executive, Mike Severino, is leaving to DewDiligence 04/13/22 12:27:08 PM
#697   Wow a $13 mil buy @ end retired early 04/03/22 10:42:52 AM
#696   FDA approves Rinvoq for second-line ulcerative colitis: DewDiligence 03/16/22 08:40:47 PM
#695   Recent investor. Looks like a safer long term retired early 03/15/22 11:19:48 AM
#694   ABBV reports positive Qulipta phase-3 in prevention of DewDiligence 03/10/22 09:34:31 AM
#693   Alvotech settles Humira-US-patent litigation with ABBV: DewDiligence 03/08/22 07:33:11 PM
#692   Skyrizi PDUFA date for Crohn’s disease extended three DewDiligence 02/28/22 07:32:11 PM
#691   Rinvoq succeeds in second Phase-3 in Crohn’s: DewDiligence 02/24/22 11:48:04 AM
#690   ATH! lilLu 02/03/22 10:13:26 AM
#689   Looking Great! lilLu 02/02/22 11:15:51 PM
#688   ABBV pipeline: DewDiligence 02/02/22 09:00:40 AM
#687   ABBV 4Q21 results: DewDiligence 02/02/22 08:59:46 AM
#686   ABBV chart oxnous 01/14/22 09:42:06 PM
#685   FDA approves Rinvoq for second-line atopic dermatitis: DewDiligence 01/14/22 01:48:26 PM
#684   ABBV JPM slide set: DewDiligence 01/11/22 07:54:14 PM
#683   FDA approves Rinvoq for second-line psoriatic arthritis: DewDiligence 12/14/21 07:07:34 PM
#682   Rinvoq hits_primary/secondary_endpoints_in phase-3 trial_in_second-line Crohn’s DewDiligence 12/06/21 11:20:18 AM
#681   JAK inhibitors—including ABBV’s Rinvoq and PFE’s Xeljanz—have new DewDiligence 12/03/21 06:47:54 PM
#680   https://seekingalpha.com/article/4465863-abbvie-abbv-undervalued-dividend-growth lilLu 11/05/21 06:58:14 PM
#679   Whatever happened to Michael Jordan drug free commercials?...Stop lilLu 11/03/21 09:04:35 AM
#678   Also the confusion of what is a real lilLu 11/03/21 08:58:05 AM
#677   Exactly. You'd be surprised how many peeps would lilLu 11/03/21 08:37:04 AM
#676   Just to be clear, some doctors share the trkyhntr 11/03/21 06:15:15 AM
#675   Never understood how marketing campaigns can be linked lilLu 11/03/21 12:44:40 AM
#674   And divi's still going strong! ITS A BUY! lilLu 11/03/21 12:41:11 AM
#673   FDA approves ABBV’s Vuity—(pilocarpine eye drops)—for presbyopia: DewDiligence 10/29/21 06:55:29 PM
#672   ABBV 3Q21 CC transcript: DewDiligence 10/29/21 04:26:08 PM
#671   ABBV 3Q21 results: DewDiligence 10/29/21 08:43:28 AM
#670   You beat me to it. Still a great lilLu 10/29/21 08:28:35 AM
#669   AbbVie Stock Gains After Hiking FY21 Earnings Outlook, fuzzy 10/29/21 08:25:49 AM
#668   Oct 29th. 3rd quarter earnings. lilLu 10/19/21 09:24:58 PM
#667   FDA approves first interchangeable Humira biosimilar—from B-I: DewDiligence 10/18/21 03:09:03 PM
#666   https://seekingalpha.com/article/4459620-abbvie-top-dividend-stock-for-long-term lilLu 10/13/21 02:00:30 PM
#665   https://seekingalpha.com/article/4458461-abbvie-appears-ready-to-reverse-and-out lilLu 10/08/21 02:49:03 AM
#664   FDA approves ABBV’s Qulipta—(atogepant)—for migraine prevention: DewDiligence 09/29/21 09:15:43 AM
#663   https://www.fool.com/investing/2021/09/27/could-abbvies-new-collaboration-be-a-b lilLu 09/28/21 10:24:30 PM
#662   https://www.fiercebiotech.com/biotech/abbvie-bets-370m-pivotal-eye-disease-gene- lilLu 09/14/21 01:24:26 AM
#661   https://www.thestreet.com/investing/abbvie-could-be-good-defensive-play lilLu 09/06/21 11:15:21 PM
#660   ABBV -8% on_new_FDA-label_warnings_for JAK inhibitors_including Rinvoq: DewDiligence 09/01/21 12:25:26 PM
#659   https://www.fool.com/investing/2021/08/15/better-dividend-stock-abbvie-or-pfizer lilLu 08/16/21 03:20:58 AM
#658   https://www.fool.com/investing/2021/08/10/3-key-takeaways-from-abbvies-second-qu lilLu 08/10/21 07:24:42 PM
PostSubject
Consent Preferences